The New 2026 Cervical Cancer Screening Rules: Can You Skip the Pap?
Federal guidelines now include a self-collected HPV swab for cervical cancer screening. Here is who it is for, and what it does not replace.

Written by Legacy OB/GYN Editorial Team. Medically reviewed by Dr. Hina Khan, MD, FACOG. Last reviewed .

A one-page recap with questions to ask, plus a small symptom tracker.
If you dread the speculum, or you have simply put off your last cervical cancer screening, there is a change worth knowing about. In early 2026, federal guidelines were updated to include a self-collected HPV swab as an option for cervical cancer screening. For average-risk women ages 30 to 65, that means you may be able to collect the sample yourself instead of having a clinician collect a Pap. Most insurance plans will be required to cover the updated screening starting in 2027.
This is a real step toward making screening easier, and cervical cancer is one of the most preventable cancers we have, so anything that helps more women stay up to date is good news. But a headline like "skip the Pap" can promise more than the change delivers. A self-swab is an HPV test, not a full exam, and a positive result still means coming in.
At Legacy OB/GYN in Frisco, TX, here is how we explain what changed, who it fits, and what it does not replace.
What changed in 2026
On January 5, 2026, the Health Resources and Services Administration (HRSA) updated its cervical cancer screening guidelines to offer average-risk women ages 30 to 65 the option to self-collect a sample for HPV testing. The update also added language requiring plans to cover the additional testing needed to complete the screening process, so that a woman who screens positive is not left with a surprise bill for the follow-up. For most insurance plans, the updated guidelines take effect in 2027.
The American College of Obstetricians and Gynecologists supported the change, noting that requiring coverage for follow-up testing removes a cost barrier many patients used to face, and brings cervical cancer screening coverage in line with colon and breast cancer screening. The move followed FDA clearance of self-collection and updated American Cancer Society guidance.
How the self-swab works
A self-collected HPV test uses a swab to gather a sample from the vagina, which is then tested in a lab for high-risk types of HPV. Because HPV causes the large majority of cervical cancers, finding the virus early is a reliable way to flag who needs a closer look.
The result sorts you into one of two paths. If the test is negative for high-risk HPV, that is reassuring, and you continue on your regular screening schedule. If the test is positive, it does not mean you have cancer. It means you need follow-up, which usually involves a clinician-collected sample for a Pap to look at the cells, and sometimes a colposcopy, a magnified look at the cervix in the office. The 2026 update is specifically designed so that this follow-up is covered.
How you get the swab can vary. Some practices and plans offer self-collection privately in the clinic, and some use a mailed kit. Because the details depend on your plan and how a practice sets it up, it is worth asking us directly how it works at Legacy.
Who it is for
The self-collection option is designed for average-risk women ages 30 to 65 who are due for routine screening.
| Your age | General screening approach | Self-collection option |
|---|---|---|
| Under 21 | Screening is not recommended | No |
| 21 to 29 | A Pap is the usual approach | Not the primary option |
| 30 to 65 | HPV-based testing, clinician-collected or self-collected | Yes, new in 2026 |
| Over 65 | Screening may end if prior results were adequate and normal | Discuss with your clinician |
The biggest benefit is for women who are behind on screening. Screening only prevents cancer if it actually happens, and up-to-date screening rates have slipped in recent years. If a self-swab is what gets someone screened who would otherwise skip it, that is a meaningful win.
What it does not replace
A self-collected HPV test is a screening tool, not a substitute for care. Two things are worth keeping in mind.
First, a self-swab does not replace follow-up. A positive result still means a clinician-collected sample and possibly a colposcopy. The self-test tells you whether you need a closer look, not whether everything is fine beyond HPV.
Second, screening is not the same as a well-woman visit. Your annual visit is where we talk about contraception, preconception and pregnancy, perimenopause and menopause, breast health, mood, and any new symptoms, and where we can examine you when something needs it. A swab in the mail does none of that. For many women the right approach is to use the convenient screening option and still keep a relationship with a clinician who knows their history. Our Pap and cervical cancer screening page explains the clinical side in more depth, and our guide to what to expect at a well-woman visit covers the rest of the picture.
Booking a visit
If you are due for cervical cancer screening, or you are not sure when you were last screened, we can sort it out and tell you honestly whether self-collection is a good fit for you. The team at Legacy Ob/Gyn see patients for exactly this kind of preventive care.
Call (972) 731-6565 or book online through the scheduling link on our website.
Frequently asked questions
Can I really screen for cervical cancer without a Pap?
What happens if my HPV test comes back positive?
Do I still need a Pap or a pelvic exam?
Who should not just self-collect?
Will my insurance cover it?
Have a question about your own situation?
Book a visit with our team at Legacy OB/GYN in Frisco. We will go through it in full, not in a hurry.
Sources (3)
- U.S. Department of Health and Human Services, WTAS: New Cervical Cancer Screening Guidelines (HRSA self-collection update) (2026)
- American Cancer Society, Self-collected vaginal specimens for HPV testing: an update to the ACS cervical cancer screening guideline (2026)
- American College of Obstetricians and Gynecologists, ACOG Responds to Updated HRSA Women's Preventive Services Guidelines on Cervical Cancer Screening (2026)
This article is general health education, not personalized medical advice. If you are experiencing a medical emergency, call 911. To talk with a Legacy OB/GYN provider, call (972) 731-6565 or book online.
This article was reviewed for medical accuracy by Dr. Hina Khan, MD, FACOG on August 25, 2026. Learn how Legacy researches, writes, and reviews →

Dr. Hina Khan, MD, FACOG
Board-Certified OB/GYN
Dr. Hina Khan is a board-certified obstetrician-gynecologist and Fellow of the American College of Obstetricians and Gynecologists. She practices at Legacy OB/GYN in Frisco, TX, with focused expertise in high-risk obstetrics, advanced gynecologic surgery, and PCOS/PMOS care. She sees patients in English, Hindi, and Urdu.
